ProMIS Neurosciences PMN Income Statement (2021-2026)

NASDAQ PMN
$14.81 -0.10 (-0.64%)
As of: Aug 21, 2026 · 12:40 PM EDT
Income Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
0.81M2.85M1.90M3.23M4.57M6.38M3.51M1.01M1.14M2.23M2.12M1.63M2.56M4.32M5.46M8.75M9.80M9.37M6.97M9.52M
Selling, General & Administrative (Quarter)
1.27M1.70M2.04M1.64M1.48M2.14M1.46M1.89M1.38M1.65M1.55M1.09M1.87M1.68M2.00M1.43M1.95M1.40M1.67M2.74M
Restructuring Costs (Quarter)
1.32M0.91M1.29M0.92M1.01M0.86M1.25M0.88M1.07M1.25M
Other Operating Expenses (Quarter)
-1.32M-0.91M-1.29M-0.92M-1.01M-0.86M-1.25M-0.88M-1.07M-1.25M
Operating Expenses (Quarter)
2.07M4.55M3.94M4.86M6.05M8.52M4.97M2.90M2.52M3.87M3.68M2.71M4.43M6.00M7.46M10.18M11.75M10.77M8.64M12.27M
Operating Income (Quarter)
-2.07M-4.55M-3.94M-4.86M-6.05M-8.52M-4.97M-2.90M-2.52M-3.87M-3.68M-2.71M-4.43M-6.00M-7.46M-10.18M-11.75M-10.80M-8.64M-12.27M
EBIT (Quarter)
-2.07M-4.55M-3.94M-4.86M-6.05M-8.52M-4.97M-2.90M-2.52M-3.87M-3.68M-2.71M-4.43M-6.00M-7.46M-10.18M-11.75M-10.80M-8.64M-12.27M
Non-operating items
Other Non Operating Income (Quarter)
0.00M0.01M0.01M0.02M0.04M0.05M0.05M0.03M0.11M0.19M0.13M0.03M0.24M0.23M0.11M0.07M0.17M0.09M0.40M0.54M
Non Operating Income (Quarter)
0.86M2.30M1.84M2.12M0.10M1.26M0.01M0.59M0.16M0.29M0.04M0.09M13.71M5.76M0.11M0.07M0.17M0.10M
Net income details
EBT (Quarter)
-2.21M-4.69M-4.09M-5.00M-6.06M-8.52M-4.97M-2.95M-2.59M-3.95M-3.83M-2.78M-4.45M-6.00M-7.46M-10.18M-11.75M-51.81M-8.72M-14.40M
Profit After Tax (Quarter)
-1.17M-2.24M-2.09M-2.75M-5.96M-7.18M-4.96M-2.48M-2.36M-3.40M-3.64M-2.62M9.28M-0.24M-7.35M-10.10M-11.60M-10.72M-8.20M-11.73M
Income from Continuing Operations (Quarter)
-2.21M-4.69M-4.09M-5.00M-6.06M-8.52M-4.97M-2.95M-2.59M-3.95M-3.83M-2.78M-4.45M-6.00M-7.46M-10.18M-11.75M-51.81M-8.72M-14.40M
Consolidated Net Income (Quarter)
-2.21M-4.69M-4.09M-5.00M-6.06M-8.52M-4.97M-2.95M-2.59M-3.95M-3.83M-2.78M-4.45M-6.00M-7.46M-10.18M-11.75M-51.81M-8.72M-14.40M
Income towards Parent Company (Quarter)
-2.21M-4.69M-4.09M-5.00M-6.06M-8.52M-4.97M-2.95M-2.59M-3.95M-3.83M-2.78M-4.45M-6.00M-7.46M-10.18M-11.75M-51.81M-8.72M-14.40M
Net Income towards Common Stockholders (Quarter)
1.17M2.14M-2.09M-2.75M-5.96M28.86M-4.96M-2.31M-2.36M-3.58M-3.64M-2.62M9.28M-0.24M-7.35M-10.12M-11.58M-10.67M-8.24M-11.73M
Additional items
EPS (Basic) (Quarter)
4.939.26-7.28-9.54-20.7096.16-14.45-6.74-4.77-7.28-4.65-3.327.72-0.23-5.27-7.26-5.93-6.08-1.26-1.28
EPS (Diluted) (Quarter)
4.939.26-7.28-9.54-20.7096.16-14.45-6.74-4.77-7.28-4.65-3.327.71-0.23-5.27-7.26-5.93-6.08-1.26-1.28
Shares Outstanding (Quarter)
0.24M0.23M0.29M0.29M0.29M0.30M0.34M0.34M0.49M0.49M0.78M0.79M1.20M1.04M1.39M1.39M1.95M1.76M6.53M9.14M
Shares Outstanding (Diluted) (Quarter)
0.24M0.23M0.29M0.29M0.29M0.30M0.34M0.34M0.49M0.49M0.78M0.79M1.20M1.06M1.39M1.39M1.95M1.76M6.53M9.14M
Shares Outstanding (Entity) (Quarter)
0.24M0.23M0.29M0.29M0.29M0.30M0.34M0.34M0.49M0.49M0.76M0.76M1.31M1.04M1.31M1.31M2.15M1.76M6.53M8.97M
EBITDA (Quarter)
-2.07M-4.55M-3.94M-4.86M-6.05M-8.52M-4.97M-2.90M-2.52M-3.87M-3.68M-2.71M-4.43M-6.00M-7.46M-10.18M-11.75M-10.80M-8.64M-12.27M
Interest Expenses (Quarter)
0.14M0.14M0.15M0.13M0.00M0.05M0.08M0.08M0.15M0.07M0.02M41.01M0.07M2.14M